MRA was honored to be chosen to deliver an Innovator Presentation at FasterCures’ 2013 Partnering For Cures meeting, held last week in New York City. The event brings together leaders from all sectors of medical research to foster collaborations critical to speeding the development of new therapies. MRA staff and leadership also attended panel sessions and networking events, and held partnering meetings with other attendees.
Wendy Selig, MRA’s President & CEO, presented our Academic-Industry partnership model as an example of successful collaboration in the drug development space. She was joined by Julia Perkins, Medical Director of Oncology at Pfizer, as they discussed the collaboration between MRA and Pfizer that was launched earlier this year.
You can read more about the genesis of MRA’s Academic-Industry partnership with Pfizer here.
We had a fabulous meeting and look forward to attending the Society for Melanoma Research (SMR) Melanoma Congress meeting next week in Philly!